Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire made its biggest ever acquisition yet in January 2015 with a $5.2 billion deal for US biotechnology company NPS Pharmaceuticals. The move came a few months after the group's sale to rival AbbVie collapsed.
Financial Data
-
31st Dec 17 Source: CRO
- €12.4 billion turnover
-
€3.5 billion
profit - 22,000 employees
-
31st Dec 16 Source: CRO
- €1.6 billion turnover
-
€115.2 million
profit - 109 employees
- 9 more years available »
Ranking
By Turnover
(€12.4 billion)- 10th in Top Companies
- 2nd in Pharma
By Employees
(22,000)- 8th in Top Companies
- 1st in Pharma
-
- 22,000
- €12.4 billion
Employees
- Flemming Ornskov CEO/Managing Director
Latest News
- 7:53pm S&P 500 reaches record high on Wall Street, European shares nudge up
- 5:13pm Bank of Ireland to sell first set of ‘bail-inable’ senior bonds
- 5:01pm Sweet deal: Valeo Foods pays £100m for maker of Fruit Salads and Dip Dabs
- 5:01pm Sweet deal: Valeo Foods pays £100m for maker of Dip Dabs
- 4:49pm American Airlines to fly Dublin-Dallas next summer